3,113
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication

, , , , , , , & ORCID Icon show all
Pages 712-721 | Received 20 Jan 2017, Accepted 10 Mar 2017, Published online: 07 Apr 2017

Figures & data

Figure 1. Structure of inhibitor 1 (left panel) and its bound conformation in the active site of the WNV NS2B-NS3 protease (right panel, PDB: 2YOLCitation19). Intermolecular polar contacts between enzyme and inhibitor are shown as dashed lines in black, the intramolecular contact stabilizing the horseshoe-like inhibitor conformation is shown in green.

Figure 1. Structure of inhibitor 1 (left panel) and its bound conformation in the active site of the WNV NS2B-NS3 protease (right panel, PDB: 2YOLCitation19). Intermolecular polar contacts between enzyme and inhibitor are shown as dashed lines in black, the intramolecular contact stabilizing the horseshoe-like inhibitor conformation is shown in green.

Figure 2. Structures and used abbreviations of unusual amino acids and acyl residues.

Figure 2. Structures and used abbreviations of unusual amino acids and acyl residues.

Scheme 1. Synthesis of inhibitors 3 and 9. HPLC analysis, used for monitoring the reactions, started at 10% solvent B. (a) Loading of 2-chlorotrityl chloride resin, Fmoc-Lys(Boc)-OH, 4 equiv. DIPEA in dry DCM, 2 h; (b) Manual Fmoc SPPS with 3 equiv. Fmoc-Phe(4-Tfa-AMe)-OH or phenylacetic acid, 3 equiv. HBTU and 6 equiv. DIPEA; Fmoc removal with 20% piperidine in DMF; (c) 1% TFA in DCM, 3 × 30 min; (d) 1 equiv. trans-1-(Cbz-amino)-4-aminomethyl-cyclohexane × HCl, 1 equiv. PyBOP, 3 equiv. DIPEA, DMF; (e) H2 and Pd/C as a catalyst in 90% acetic acid, stirring overnight at r.t.; (f) 3–6 equiv. 1H-pyrazole-1-carboxamidine × HCl, 4 equiv. DIPEA in DMF, 16 h; (g) 1 M NaOH in dioxane/water, pH 12 at r.t. 3 h, neutralization by 10% TFA; (h) 90% TFA, at r.t. 1 h, preparative HPLC. All HPLC measurements of intermediates started at 10% solvent B, the analysis of the more hydrophilic final inhibitors 3 and 9 started at 1% solvent B.

Scheme 1. Synthesis of inhibitors 3 and 9. HPLC analysis, used for monitoring the reactions, started at 10% solvent B. (a) Loading of 2-chlorotrityl chloride resin, Fmoc-Lys(Boc)-OH, 4 equiv. DIPEA in dry DCM, 2 h; (b) Manual Fmoc SPPS with 3 equiv. Fmoc-Phe(4-Tfa-AMe)-OH or phenylacetic acid, 3 equiv. HBTU and 6 equiv. DIPEA; Fmoc removal with 20% piperidine in DMF; (c) 1% TFA in DCM, 3 × 30 min; (d) 1 equiv. trans-1-(Cbz-amino)-4-aminomethyl-cyclohexane × HCl, 1 equiv. PyBOP, 3 equiv. DIPEA, DMF; (e) H2 and Pd/C as a catalyst in 90% acetic acid, stirring overnight at r.t.; (f) 3–6 equiv. 1H-pyrazole-1-carboxamidine × HCl, 4 equiv. DIPEA in DMF, 16 h; (g) 1 M NaOH in dioxane/water, pH 12 at r.t. 3 h, neutralization by 10% TFA; (h) 90% TFA, at r.t. 1 h, preparative HPLC. All HPLC measurements of intermediates started at 10% solvent B, the analysis of the more hydrophilic final inhibitors 3 and 9 started at 1% solvent B.

Table 1. Analytical data and inhibition of the WNV and DENV NS2B-NS3 proteases by inhibitors of the formula.

Table 3. Chimeric furin, WNV and DENV-2 NS2B-NS3 protease inhibitors of the formula.

Figure 3. Dixon plot for the inhibition of the WNV NS2B-NS3 protease by inhibitor 37. Kinetic measurements have been performed with three different concentrations of the substrate Phac-Leu-Lys-Lys-Arg-AMC at 100 (•), 50 (^), and 25 μM (▾) using various inhibitor concentrations. The dashed line represents 1/Vmax, which was obtained from a Michaelis–Menten plot determined in parallel on the same 96-well plate.

Figure 3. Dixon plot for the inhibition of the WNV NS2B-NS3 protease by inhibitor 37. Kinetic measurements have been performed with three different concentrations of the substrate Phac-Leu-Lys-Lys-Arg-AMC at 100 (•), 50 (^), and 25 μM (▾) using various inhibitor concentrations. The dashed line represents 1/Vmax, which was obtained from a Michaelis–Menten plot determined in parallel on the same 96-well plate.

Table 2. Analytical data and inhibition of the WNV and DENV NS2B-NS3 protease by peptides of the formula P4-Lys-Lys-Arg-R′ (HPLC measurements started at 1% solvent B).

Figure 4. Reduction of WNV (A) and DENV-2 (B) propagation by inhibitors 4548. The number of formed infectious viruses (virus yield ± standard deviation, n = 3) was determined at 48 h postinfection from the supernatant of infected cells by a plaque assay. The nucleoside analog ribavirin was used as a reference.

Figure 4. Reduction of WNV (A) and DENV-2 (B) propagation by inhibitors 45–48. The number of formed infectious viruses (virus yield ± standard deviation, n = 3) was determined at 48 h postinfection from the supernatant of infected cells by a plaque assay. The nucleoside analog ribavirin was used as a reference.